Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xspray Pharma Major Shareholding Notification 2022

Oct 31, 2022

3129_iss_2022-10-31_bb1a5d8d-54a0-4a06-bb46-6bff9179d325.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer XSpray Pharma AB (publ)

Holder

Flerie Invest AB

Instrument

Instrument Aktier SE0009973563
Before the transaction
Shares 3,022,378
Voting rights 3,022,378
Transaction
Reason for major shareholding notification New share issue
Date 31/10/2022
Limit for number of shares 15 %
Limit for number of votes 15 %
After the transaction
Quantity
Shares 3,439,378
Directly held voting rights 3,439,378
Indirectly held voting rights 0
Percentage
Directly held shares 15.16453 %
Directly held voting rights 15.16453 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 15.16453 % 3,439,378
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 15.16453 % 3,439,378
Group
total
holdings
Voting rights
3,439,378
Percentage of voting rights 15.16453
Published
31/10/2022 15:41
Contact
Name
Cecilia Schéele
Phone
+46706006856 Email [email protected]
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25